Dr. Thomas A. Burrow, MD
Medical Genetics (Clinical Genetics (M.D.) Physician)
- Medicare participating
At a glance
- Medical school
- University of Arkansas College of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 12
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: University of Arkansas College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Genetics (M.D.) Physician primary
AR license E-9899 · OH license 35.085280
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Arkansas Medical Sciences Little Rock, AR
- Arkansas Children's Hospital Little Rock, AR
Medical groups
- Arkansas Childrens Professional Services Organization LLC (184 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 12
- Services billed
- 12
- Patients’ average age
- 46
| Service | Times | Patients |
|---|---|---|
| Insertion of needle into vein for collection of blood sample | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Dojolvi (triheptanoin) | 12 |
| Levocarnitine (levocarnitine (with sugar)) | 11 |
| Metronidazole Other prescribers in Little Rock, AR | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 6 payments worth $15,578 in total to this clinician.
| ModernaTX, Inc. | $9,650 |
|---|---|
| Genzyme Corporation | $3,305 |
| Intrabio Inc | $1,575 |
| Alexion Pharmaceuticals, Inc. | $1,025 |
| Eton Pharmaceuticals, Inc. | $23.16 |
| Consulting Fee | $13,980 |
|---|---|
| Honoraria | $1,575 |
| Food and Beverage | $23.16 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| ModernaTX, Inc. Jul 3, 2025 | Consulting Fee | $9,250 |
| Genzyme Corporation Mar 28, 2025 | Consulting Fee | $3,305 |
| Intrabio Inc May 30, 2025 | Honoraria AQNEURSA · NEUROLOGY | $1,575 |
| Alexion Pharmaceuticals, Inc. Nov 20, 2025 | Consulting Fee STRENSIQ · Rare Disease | $1,025 |
| ModernaTX, Inc. Jul 3, 2025 | Consulting Fee | $400 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 6 companies. The companies reported $222,849 in research payments for these studies, mostly to the institutions running them.
- Study name not reported
Ultragenyx Pharmaceutical Inc. - Pompe Disease Registry Protocol
Sanofi US Services Inc. · Recruiting · NCT00231400 - A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With LOPD
Amicus Therapeutics, Inc. - Fabry Disease Registry & Pregnancy Sub-registry
Sanofi US Services Inc. · Recruiting · NCT00196742 - Gaucher disease outcome survey (gos) an observational, international, multicenter, long-term registry of patients with gaucher disease
Takeda Pharmaceuticals U.S.A., Inc. - International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Sanofi US Services Inc. · Recruiting · NCT00358943 - Gaucher LSD Data Registry
Genzyme Corporation - Mucopolysaccharidosis I (MPS I) Registry
Sanofi US Services Inc. · Completed · NCT00144794 - BMN165-306
BioMarin Pharmaceutical Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.